Tower Research Capital LLC (Trc) Eledon Pharmaceuticals, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.29 Billion
- Q1 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Eledon Pharmaceuticals, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 12,478 shares of ELDN stock, worth $33,565. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,478
Previous 7,944
57.07%
Holding current value
$33,565
Previous $32,000
31.25%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding ELDN
# of Institutions
86Shares Held
37.1MCall Options Held
10.5KPut Options Held
66.8K-
Bvf Inc San Francisco, CA6.29MShares$16.9 Million0.94% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.57MShares$9.59 Million0.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.95MShares$7.94 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN2.33MShares$6.26 Million1.01% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L32.31MShares$6.21 Million2.06% of portfolio
About Eledon Pharmaceuticals, Inc.
- Ticker ELDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,756,800
- Market Cap $37M
- Description
- Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...